CD146 as an adverse prognostic factor in uterine sarcoma

BACKGROUND: Uterine sarcoma is an aggressive malignancy with a poor prognosis. This study aimed to determine the expression of CD146, P53, and Ki-67 in uterine sarcoma and to evaluate their prognostic significance. METHODS: We retrospectively analyzed the prognosis and clinicopathologic features of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yun, Huang, He, Yuan, Lin-Jing, Xiong, Ying, Huang, Xin, Lin, Jia-Xin, Zheng, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546164/
https://www.ncbi.nlm.nih.gov/pubmed/26293576
http://dx.doi.org/10.1186/s40001-015-0160-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546164/
https://www.ncbi.nlm.nih.gov/pubmed/26293576
http://dx.doi.org/10.1186/s40001-015-0160-2

Ejemplares similares